Skip to content

Pelvic Microbiomes of Benign and Malignant Ovarian Diseases

The Role of Pelvic Microbiomes During the Malignant Transformation of Benign Ovarian Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03388996
Acronym
MTBOD-1
Enrollment
40
Registered
2018-01-03
Start date
2018-01-01
Completion date
2021-01-01
Last updated
2018-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microbiota, Ovarian Neoplasms, Ribosome Alteration

Brief summary

This case-control study aims to compare the pelvic microbiomes of benign ovarian diseases and ovarian malignancies by 16s RNA techniques and culture. Discharges/flushing fluid from vagina, faces and fimbria end of fallopian tube are collected from age and menopausal status matched patient before and during procedures of laparoscopies. The discharges/flushing fluid would be sent for 16s RNA analysis and microculture respectively, and the results would get self-contrasted comparison and case-control comparison.

Interventions

DIAGNOSTIC_TESTmicrobiomes

16s RNA analysis and microculture of discharges/flushing fluid from vagina, faces and fimbria end of fallopian tube

Sponsors

Academy Military Medical Science, China
CollaboratorINDUSTRY
Lei Li
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Laparoscopy procedures * Specific pathological diagnosis

Exclusion criteria

* Previous history of pelvic surgeries * Evidences of pelvic inflammation diseases

Design outcomes

Primary

MeasureTime frameDescription
Difference of species distribution of microorganism according to 16s RNA analysis2 yearsThe difference of species of microorganism distribution according to 16s RNA sequencing analysis between control group and study group, and between different sampling sites in each arm
Difference of species distribution of microorganism according to microculture outcomes2 yearsDifference of species distribution of microorganism according to microculture outcomes between control group and study group, and between different sampling sites in each arm

Countries

China

Contacts

Primary ContactLei Li, MD
lileigh@163.com008613911988831
Backup ContactLan Zhu, MD
zhu_julie@vip.sina.com008613911714696

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026